Literature DB >> 2649293

Insulin autoantibodies in non-obese diabetic (NOD) mice.

C Michel1, C Boitard, J F Bach.   

Abstract

Anti-insulin autoantibodies were detected in NOD mice using ELISA. The antibodies were detected as early as at 5 weeks of age, long before onset of clinically overt diabetes, especially in diabetes-prone female mice. The anti-insulin specificity was verified by passage on affinity chromatography insulin columns and demonstration that the anti-insulin activity was located on the F(ab')2 region of the immunoglobulins. The presence of anti-insulin antibodies in prediabetic NOD mice provides a unique possibility for studying their significance and their eventual pathogenic role in the development of insulin-dependent diabetes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649293      PMCID: PMC1541951     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

Review 2.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

3.  Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure.

Authors:  J S Soeldner; M Tuttleman; S Srikanta; O P Ganda; G S Eisenbarth
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

4.  Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  O Pontesilli; P Carotenuto; L S Gazda; P F Pratt; S J Prowse
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

5.  Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy.

Authors:  S A Arslanian; D J Becker; B Rabin; R Atchison; M Eberhardt; D Cavender; J Dorman; A L Drash
Journal:  Diabetes       Date:  1985-09       Impact factor: 9.461

6.  Insulin autoantibodies, islet cell surface antibodies and the development of spontaneous diabetes in the BB/Edinburgh rat.

Authors:  B M Dean; A J Bone; A M Varey; R Walker; J D Baird; A Cooke
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

7.  Insulin antibodies in insulin-dependent diabetics before insulin treatment.

Authors:  J P Palmer; C M Asplin; P Clemons; K Lyen; O Tatpati; P K Raghu; T L Paquette
Journal:  Science       Date:  1983-12-23       Impact factor: 47.728

8.  Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus.

Authors:  T Wilkin; P J Hoskins; M Armitage; M Rodier; C Casey; J L Diaz; D A Pyke; R D Leslie
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

9.  Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage.

Authors:  G F Bottazzo; B M Dean; A N Gorsuch; A G Cudworth; D Doniach
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

10.  High frequency of natural autoantibodies in normal newborn mice.

Authors:  G Dighiero; P Lymberi; D Holmberg; I Lundquist; A Coutinho; S Avrameas
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

View more
  12 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.

Authors:  A Lehuen; J Altman; J F Bach; C Carnaud
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  Beta2-glycoprotein I-dependent and -independent anticardiolipin antibody in non-obese diabetic (NOD) mice.

Authors:  K Anzai; S Nagafuchi; Y Niho; M Kikuchi; J Ono
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.

Authors:  Xuezhi Dai; Richard G James; Tania Habib; Swati Singh; Shaun Jackson; Socheath Khim; Randall T Moon; Denny Liggitt; Alejandro Wolf-Yadlin; Jane H Buckner; David J Rawlings
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

5.  Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.

Authors:  Marc Throsby; Josiane Coulaud; Sylvie Durant; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-08-10

6.  Absence of autoantibodies against glutamate decarboxylase (GAD) in the non-obese diabetic (NOD) mouse and low expression of the enzyme in mouse islets.

Authors:  L A Velloso; D L Eizirik; F A Karlsson; O Kämpe
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

7.  Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.

Authors:  Christina Amatya; Ilian A Radichev; Jacob Ellefson; Mark Williams; Alexei Y Savinov
Journal:  Mol Ther       Date:  2017-09-07       Impact factor: 11.454

8.  Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.

Authors:  Shi-Wu Li; Vijay Koya; Yi Li; William Donelan; Peng Lin; Westley H Reeves; Li-Jun Yang
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

9.  Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.

Authors:  Carolin Daniel; Benno Weigmann; Roderick Bronson; Harald von Boehmer
Journal:  J Exp Med       Date:  2011-06-20       Impact factor: 14.307

Review 10.  The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.

Authors:  James A Pearson; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2015-09-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.